Added to YB: 2025-08-08
Pitch date: 2025-08-06
HIMS [neutral]
Hims & Hers Health, Inc.
-60.72%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$51.76
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
growth
Hims & Hers Q2’25: The Good and the Bad
HIMS (earnings update): Q2'25 revenue $545M (+73% YOY) but -7% QoQ due to GLP-1 sales drop ($190M vs $230M Q1). Core business stagnant at $355M. Net income +220% to $43M, but cash flow negative $19M. Growth strategy: global expansion, blood tests (cancer diagnostics TAM $109B), and longevity peptides.
Read full article (7 min)